SG3 Management’s Lyell Immunopharma LYEL Stock Holding History

SG3 Management’s Portfolio LYEL Stock Details LYEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-30,000	Closed	-$3.91M	–	386
2022 Q2	$3.91M	Hold	30,000	–	–	0.46%	49
2022 Q1	$3.03M	Buy	+30,000	New	+$3.63M	0.09%	217

Other funds holding LYEL

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Apoletto Road Town, Tortola, British Virgin Islands $260M AUM 31.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return